These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tunable and reversible drug control of protein production via a self-excising degron. Chung HK; Jacobs CL; Huo Y; Yang J; Krumm SA; Plemper RK; Tsien RY; Lin MZ Nat Chem Biol; 2015 Sep; 11(9):713-20. PubMed ID: 26214256 [TBL] [Abstract][Full Text] [Related]
4. Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target. Cummings MD; Lindberg J; Lin TI; de Kock H; Lenz O; Lilja E; Felländer S; Baraznenok V; Nyström S; Nilsson M; Vrang L; Edlund M; Rosenquist A; Samuelsson B; Raboisson P; Simmen K Angew Chem Int Ed Engl; 2010 Feb; 49(9):1652-5. PubMed ID: 20166108 [No Abstract] [Full Text] [Related]
5. Norwalk virus nonstructural protein p48 forms a complex with the SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G protein. Ettayebi K; Hardy ME J Virol; 2003 Nov; 77(21):11790-7. PubMed ID: 14557663 [TBL] [Abstract][Full Text] [Related]
6. Imaging of metabolites by using a fusion protein between a periplasmic binding protein and GFP derivatives: from a chimera to a view of reality. Stitt M Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9614-6. PubMed ID: 12119424 [No Abstract] [Full Text] [Related]
7. TMC-435, an NS3/4A protease inhibitor for the treatment of HCV infection. Tsantrizos YS Curr Opin Investig Drugs; 2009 Aug; 10(8):871-81. PubMed ID: 19649931 [TBL] [Abstract][Full Text] [Related]
8. Cellular translocation of proteins by transportan. Pooga M; Kut C; Kihlmark M; Hällbrink M; Fernaeus S; Raid R; Land T; Hallberg E; Bartfai T; Langel U FASEB J; 2001 Jun; 15(8):1451-3. PubMed ID: 11387254 [No Abstract] [Full Text] [Related]
9. Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli. Mori A; Yamada K; Kimura J; Koide T; Yuasa S; Yamada E; Miyamura T FEBS Lett; 1996 Jan; 378(1):37-42. PubMed ID: 8549798 [TBL] [Abstract][Full Text] [Related]
10. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A. Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853 [TBL] [Abstract][Full Text] [Related]
13. Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease. Kirschberg TA; Squires NH; Yang H; Corsa AC; Tian Y; Tirunagari N; Sheng XC; Kim CU Bioorg Med Chem Lett; 2014 Feb; 24(3):969-72. PubMed ID: 24405705 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the zinc binding activity of the rubella virus nonstructural protease. Liu X; Yang J; Ghazi AM; Frey TK J Virol; 2000 Jul; 74(13):5949-56. PubMed ID: 10846076 [TBL] [Abstract][Full Text] [Related]
15. The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. Cappelletti P; Campomenosi P; Pollegioni L; Sacchi S FEBS J; 2014 Feb; 281(3):708-23. PubMed ID: 24237903 [TBL] [Abstract][Full Text] [Related]
16. Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug-Drug Interactions. Eley T; Garimella T; Li W; Bertz RJ Clin Pharmacokinet; 2015 Dec; 54(12):1205-22. PubMed ID: 26177803 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350. Raboisson P; de Kock H; Rosenquist A; Nilsson M; Salvador-Oden L; Lin TI; Roue N; Ivanov V; Wähling H; Wickström K; Hamelink E; Edlund M; Vrang L; Vendeville S; Van de Vreken W; McGowan D; Tahri A; Hu L; Boutton C; Lenz O; Delouvroy F; Pille G; Surleraux D; Wigerinck P; Samuelsson B; Simmen K Bioorg Med Chem Lett; 2008 Sep; 18(17):4853-8. PubMed ID: 18678486 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors. Boloor A; Hanway D; Joshi M; Winn DT; Mendez G; Walls M; Wei P; Qian F; Zhang X; Zhang Y; Hepperle ME; Li X; Campbell DA; Betancort JM Bioorg Med Chem Lett; 2009 Oct; 19(19):5708-11. PubMed ID: 19713109 [TBL] [Abstract][Full Text] [Related]
19. Fluorescent proteins in single- and multicolor flow cytometry. Lybarger L; Chervenak R Methods Enzymol; 1999; 302():189-99. PubMed ID: 12876771 [No Abstract] [Full Text] [Related]